Literature DB >> 1988228

Measurement of interleukin-6 in bronchoalveolar lavage fluid by radioimmunoassay: differences between patients with interstitial lung disease and control subjects.

K P Jones1, S P Reynolds, S J Capper, S Kalinka, J H Edwards, B H Davies.   

Abstract

Bronchoalveolar lavage fluid (BALF) from subjects with a variety of interstitial lung diseases (active sarcoidosis, pigeon breeders' disease (PBD), asymptomatic pigeon breeders, patients with idiopathic pulmonary fibrosis) and from control subjects were assayed for interleukin-6 (IL-6) using a novel radioimmunoassay system. IL-6 was detectable in BALF from all groups, with disease groups showing significantly increased IL-6 levels compared with controls (P less than 0.01 in all cases). When these results were standardized, using urea to compensate for dilution effects in the BALF, only the asymptomatic pigeon breeders had significantly higher IL-6 levels than the controls (P less than 0.025), with all other groups showing no difference. When albumin was used for standardization, both the PBD group (P less than 0.001) and the sarcoidosis patients (P less than 0.01) had considerably lower levels of IL-6 than the control subjects. Using either albumin or urea for standardization, the PBD patients had significantly lower levels of IL-6 than do their asymptomatic counterparts (P less than 0.001 in both cases). This is contrasted by the finding of greatly elevated levels of IgG in the BALF of the PBD patients compared with asymptomatics (P less than 0.001). There was, however, no relation between IL-6 and IgG in any patient group, although the PBD patients had the lowest IL-6 and highest IgG as a group. These findings may suggest a mechanism by which asymptomatic subjects remain free from clinical complaints.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1988228      PMCID: PMC1535454          DOI: 10.1111/j.1365-2249.1991.tb05583.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  26 in total

1.  Monocyte-derived human B-cell growth factor identified as interferon-beta 2 (BSF-2, IL-6).

Authors:  G Tosato; K B Seamon; N D Goldman; P B Sehgal; L T May; G C Washington; K D Jones; S E Pike
Journal:  Science       Date:  1988-01-29       Impact factor: 47.728

2.  Interferon beta 2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells.

Authors:  J Gauldie; C Richards; D Harnish; P Lansdorp; H Baumann
Journal:  Proc Natl Acad Sci U S A       Date:  1987-10       Impact factor: 11.205

3.  Limitations of using urea to quantify epithelial lining fluid recovered by bronchoalveolar lavage.

Authors:  T W Marcy; W W Merrill; J A Rankin; H Y Reynolds
Journal:  Am Rev Respir Dis       Date:  1987-06

4.  Anatomical distribution of bronchoalveolar lavage fluid as assessed by digital subtraction radiography.

Authors:  C A Kelly; C J Kotre; C Ward; D J Hendrick; E H Walters
Journal:  Thorax       Date:  1987-08       Impact factor: 9.139

5.  Transcriptional regulation of the interferon-beta 2/B cell differentiation factor BSF-2/hepatocyte-stimulating factor gene in human fibroblasts by other cytokines.

Authors:  Z Walther; L T May; P B Sehgal
Journal:  J Immunol       Date:  1988-02-01       Impact factor: 5.422

6.  B-cell-stimulatory factor 2 (beta 2 interferon) functions as a second signal for interleukin 2 production by mature murine T cells.

Authors:  R D Garman; K A Jacobs; S C Clark; D H Raulet
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

7.  B cell stimulatory factor-2 is involved in the differentiation of cytotoxic T lymphocytes.

Authors:  Y Takai; G G Wong; S C Clark; S J Burakoff; S H Herrmann
Journal:  J Immunol       Date:  1988-01-15       Impact factor: 5.422

8.  Elevated concentrations of soluble interleukin-2 receptors in serum samples and bronchoalveolar lavage fluids in active sarcoidosis.

Authors:  E C Lawrence; K P Brousseau; M B Berger; C C Kurman; L Marcon; D L Nelson
Journal:  Am Rev Respir Dis       Date:  1988-04

9.  Receptors for B cell stimulatory factor 2. Quantitation, specificity, distribution, and regulation of their expression.

Authors:  T Taga; Y Kawanishi; R R Hardy; T Hirano; T Kishimoto
Journal:  J Exp Med       Date:  1987-10-01       Impact factor: 14.307

10.  Identification of the human 26-kD protein, interferon beta 2 (IFN-beta 2), as a B cell hybridoma/plasmacytoma growth factor induced by interleukin 1 and tumor necrosis factor.

Authors:  J Van Damme; G Opdenakker; R J Simpson; M R Rubira; S Cayphas; A Vink; A Billiau; J Van Snick
Journal:  J Exp Med       Date:  1987-03-01       Impact factor: 14.307

View more
  10 in total

1.  Pulmonary toxicity of indium-tin oxide production facility particles in rats.

Authors:  Melissa A Badding; Natalie R Fix; Marlene S Orandle; Mark W Barger; Katherine M Dunnick; Kristin J Cummings; Stephen S Leonard
Journal:  J Appl Toxicol       Date:  2015-10-15       Impact factor: 3.446

2.  Epithelial cells release proinflammatory cytokines and undergo c-Myc-induced apoptosis on exposure to filarial parasitic sheath protein-Bcl2 mediates rescue by activating c-H-Ras.

Authors:  B Krishnamoorthy; K Narayanan; S Miyamoto; A Balakrishnan
Journal:  In Vitro Cell Dev Biol Anim       Date:  2000-09       Impact factor: 2.416

3.  Relationship between pulmonary oxygen consumption, lung inflammation, and calculated venous admixture in patients with acute lung injury.

Authors:  P Jolliet; J B Thorens; L Nicod; C Pichard; U Kyle; J C Chevrolet
Journal:  Intensive Care Med       Date:  1996-04       Impact factor: 17.440

4.  Bradykinin stimulates type II alveolar cells to release neutrophil and monocyte chemotactic activity and inflammatory cytokines.

Authors:  S Koyama; E Sato; H Nomura; K Kubo; M Miura; T Yamashita; S Nagai; T Izumi
Journal:  Am J Pathol       Date:  1998-12       Impact factor: 4.307

5.  Alveolar type II epithelial cells produce interleukin-6 in vitro and in vivo. Regulation by alveolar macrophage secretory products.

Authors:  B Crestani; P Cornillet; M Dehoux; C Rolland; M Guenounou; M Aubier
Journal:  J Clin Invest       Date:  1994-08       Impact factor: 14.808

6.  Increased interleukin 6 production by bronchoalveolar lavage cells in patients with active sarcoidosis.

Authors:  J Homolka; J Müller-Quernheim
Journal:  Lung       Date:  1993       Impact factor: 2.584

7.  Evaluation of soluble IL-6 receptor concentration in serum and epithelial lining fluid from patients with interstitial lung diseases.

Authors:  A Yokoyama; N Kohno; Y Hirasawa; K Kondo; M Abe; Y Inoue; S Fujioka; S Fujino; S Ishida; K Hiwada
Journal:  Clin Exp Immunol       Date:  1995-05       Impact factor: 4.330

8.  Cytokine gene polymorphisms in Pigeon Breeder's Disease expression.

Authors:  Cláudia Freitas; Bruno Lima; Natália Martins; Natália Melo; Patrícia Mota; Hélder Novais-Bastos; Helena Alves; Oksana Sokhatska; Luís Delgado; António Morais
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2020-09-30       Impact factor: 0.670

9.  Monoclonal immunoglobulin A antibody directed against serotype-specific epitope of Shigella flexneri lipopolysaccharide protects against murine experimental shigellosis.

Authors:  A Phalipon; M Kaufmann; P Michetti; J M Cavaillon; M Huerre; P Sansonetti; J P Kraehenbuhl
Journal:  J Exp Med       Date:  1995-09-01       Impact factor: 14.307

Review 10.  Hydrogen Peroxide and Sodium Transport in the Lung and Kidney.

Authors:  V Shlyonsky; A Boom; F Mies
Journal:  Biomed Res Int       Date:  2016-03-17       Impact factor: 3.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.